Traders Rush To Buy Biotech Following Q1 Earnings Beat
07 Mayo 2024 - 10:55AM
AllPennyStocks.com
A California-based biotech company is stealing
the show so far during Tuesday’s session after the company reported
Q1 2024 earnings after yesterday’s market...
To read the full story on AllPennyStocks.com, click
here.
FibroGen (NASDAQ:FGEN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
FibroGen (NASDAQ:FGEN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
